Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07222514 · ClinicalTrials.gov registry record · NA
Feasibility and Safety of Single-Port Robotic-Assisted Deep Inferior Epigastric Pedicle Flap Harvest
A NA study of DIEP Flap Breast Reconstruction, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT07222514 is a NA study of DIEP Flap Breast Reconstruction that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 4 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07222514, a NA study of DIEP Flap Breast Reconstruction, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this study is to evaluate the feasibility of single-port robotic surgery for DIEP flap breast reconstruction. The investigators will also investigate complications of the procedure, incision length, flap success rate, post operative pain, vascular pedicle length and caliber, and VMP-B score (quality of life/satisfaction of breast procedures survey).
Conditions Studied
Interventions
- DEVICE Single-Port Robotic System
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2026-02 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07222514
The ClinicalTrials.gov registry entry for NCT07222514 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with DIEP Flap Breast Reconstruction appearing as the primary indexed condition, and to 1 intervention - of which Single-Port Robotic System is the first listed.
NCT07222514 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT07222514 about?
NCT07222514 is a clinical study titled "Feasibility and Safety of Single-Port Robotic-Assisted Deep Inferior Epigastric Pedicle Flap Harvest". The primary aim of this study is to evaluate the feasibility of single-port robotic surgery for DIEP flap breast reconstruction. The investigators will also investigate complications of the procedure, incision length, flap success rate, post operative pain, vascular pedicle length and caliber, and V...
What is the current status of trial NCT07222514?
This trial is currently recruiting. It is a NA study. The enrollment target is 4 participants. The study started on 2026-02. Estimated completion is 2027-12.
What conditions does trial NCT07222514 study?
This clinical trial studies the following conditions: DIEP Flap Breast Reconstruction.
What interventions are being tested in trial NCT07222514?
The interventions under investigation include: Single-Port Robotic System (DEVICE).
Who is sponsoring clinical trial NCT07222514?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07222514 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.